Lawson Research Institute

🇨🇦Canada

Country: 🇨🇦Canada

Ownership: Private

Established: 1983-01-01

Employees: -

Market Cap: -

Website: http://www.lawsonresearch.ca

Clinical Trials

Effect of Macugen(Pegaptanib)on Surgical Outcomes and VEGF Levels in Diabetic Patients With PDR (Diabetic Retinopathy or CSDME (Macular Edema)

Not Applicable

Completed

Conditions: Proliferative Diabetic Retinopathy
Diabetic Macular Edema

Interventions: Drug: Macugen (Pegaptanib)

First Posted Date: 2007-03-12

Last Posted Date: 2012-04-19

Lead Sponsor: Lawson Health Research Institute

Target Recruit Count: 28

Registration Number: NCT00446381

Locations: 🇨🇦
Ivey Eye Institute, St. Joseph's Health Care Centre, London, Ontario, Canada

Comparison of GlideScope Specific Stylet to Malleable Stylet for GlideScope Intubation

Not Applicable

Completed

Conditions: Intubation, Endotracheal

First Posted Date: 2007-02-13

Last Posted Date: 2008-10-16

Lead Sponsor: Lawson Health Research Institute

Target Recruit Count: 70

Registration Number: NCT00434720

Locations: 🇨🇦
London Health Sciences Center, London, Ontario, Canada

PERIOP 2 - A Safety and Effectiveness of LMWH vs Placebo Bridging Therapy for Patients on Long Term Warfarin Requiring Temporary Interruption of Warfarin.

Phase 3

Conditions: Stroke

Interventions: Other: Placebo
Drug: Dalteparin

First Posted Date: 2007-02-08

Last Posted Date: 2020-02-19

Lead Sponsor: Lawson Health Research Institute

Target Recruit Count: 1473

Registration Number: NCT00432796

Locations: 🇨🇦
Hamilton Health Sciences Corporation-Henderson Site, Hamilton, Ontario, Canada
🇮🇳
Care Hospital, Hyderabad, Nampally, India
🇮🇳
Sir Ganga Ram Hospital, New Delhi, India

and more 5 locations

Exercise Training, Insulin Resistance and Coronary Artery Disease

Phase 3

Completed

Conditions: Coronary Artery Disease
Glucose Intolerance

First Posted Date: 2006-12-18

Last Posted Date: 2017-08-28

Lead Sponsor: Lawson Health Research Institute

Target Recruit Count: 60

Registration Number: NCT00412815

Locations: 🇨🇦
Hamilton Health Sciences Centre, Hamilton, Ontario, Canada

Efficacy Study of Panax Ginseng to Boost Antipsychotics Effects in Schizophrenia

Phase 1

Completed

Conditions: Schizophrenia
Schizoaffective Disorder
Tardive Dyskinesia
Insulin Resistance
Obesity

Interventions: Drug: Panax Ginseng

First Posted Date: 2006-11-17

Last Posted Date: 2012-12-12

Lead Sponsor: Lawson Health Research Institute

Target Recruit Count: 60

Registration Number: NCT00401089

Locations: 🇨🇦
Regional Mental Health Care London, St. Thomas, Ontario, Canada
🇨🇦
Queen's University, Kingston, Ontario, Canada
🇬🇧
Northwick Park Hospital, Harrow, Middlesex, United Kingdom

and more 1 locations

Comparison of GlideScope Videolaryngoscopy to Direct Laryngoscopy for Nasal Intubation

Not Applicable

Completed

Conditions: Nasal Intubation

First Posted Date: 2006-11-17

Last Posted Date: 2021-10-29

Lead Sponsor: Lawson Health Research Institute

Target Recruit Count: 70

Registration Number: NCT00400972

Locations: 🇨🇦
London Health Sciences Centre, London, Ontario, Canada

PET/CT to Image Hypoxia in Head and Neck Tumours

Early Phase 1

Completed

Conditions: Head and Neck Cancer

First Posted Date: 2006-11-02

Last Posted Date: 2017-08-28

Lead Sponsor: Lawson Health Research Institute

Target Recruit Count: 17

Registration Number: NCT00395109

Locations: 🇨🇦
London Health Science Center, London, Ontario, Canada

Combination Therapy for Age-Related Macular Degeneration.

Phase 2

Completed

Conditions: Age Related Macular Degeneration

Interventions: Drug: Avastin (Bevacizumab)
Drug: Bevacizumab

First Posted Date: 2006-09-15

Last Posted Date: 2011-09-28

Lead Sponsor: Lawson Health Research Institute

Target Recruit Count: 103

Registration Number: NCT00376701

Locations: 🇨🇦
The University of British Columbia, Vancouver, British Columbia, Canada
🇨🇦
The University of Alberta and Capital Health, Edmonton, Alberta, Canada
🇨🇦
Dr. Stanley G. Shortt, Victoria, British Columbia, Canada

and more 2 locations

Diabetes Screening, Risk Management and Disease Management in a High-Risk Mental Health Population Part II

Completed

Conditions: Schizophrenia
Psychotic Disorders
Diabetes Mellitus

First Posted Date: 2006-09-15

Last Posted Date: 2018-11-06

Lead Sponsor: Lawson Health Research Institute

Target Recruit Count: 39

Registration Number: NCT00377117

Locations: 🇨🇦
Regional Mental Health Care London, London, Ontario, Canada

Bumetanide Versus Furosemide in Heart Failure

Phase 3

Withdrawn

Conditions: Heart Failure

Interventions: Drug: furosemide
Drug: bumetanide

First Posted Date: 2006-09-07

Last Posted Date: 2014-03-27

Lead Sponsor: Lawson Health Research Institute

Registration Number: NCT00372762

Locations: 🇨🇦
University Hospital, London Health Sciences Centre, London, Ontario, Canada

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy